Expression of the G2-M Modulators in Pancreatic Adenocarcinoma

Publisher： Karger

E-ISSN： 1424-3911|2|2|138-145

ISSN： 1424-3903

Source： Pancreatology, Vol.2, Iss.2, 2002-04, pp. : 138-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1392-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of E-Cadherin, Alpha- and Beta-Catenins in Patients with Pancreatic Adenocarcinoma

By  

Pancreatology, Vol. 2, Iss. 2, 2002-04 ,pp. : 129-137

Karger

Access to resources Recommend Favorite

Expression and Clinical Significance of the G1-S Modulators in Intrahepatic Cholangiocellular Carcinoma

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 242-251

Karger

Access to resources Recommend Favorite

BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 205-210

Karger

Access to resources Recommend Favorite

Expression Profiles of a Human Pancreatic Cancer Cell Line upon Induction of Apoptosis Search for Modulators in Cancer Therapy

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 277-290

Karger

Access to resources Recommend Favorite